<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02181140</url>
  </required_header>
  <id_info>
    <org_study_id>PV 3835</org_study_id>
    <nct_id>NCT02181140</nct_id>
  </id_info>
  <brief_title>Core Biopsy Endo Sonography Study Evaluation of the Significance of the Pro-core® Needle</brief_title>
  <acronym>COS</acronym>
  <official_title>Prospective Evaluation of the Significance of the Pro-core® Needle in Differential Diagnosis of Tumorous and Inflammatory Processes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitätsklinikum Hamburg-Eppendorf</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitätsklinikum Hamburg-Eppendorf</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is designed to evaluate the diagnostic accuracy of a new designed endoscopic
      ultrasonography (EUS) Core biopsy aspiration needle in comparison to a conventional EUS
      aspiration needle in GI-tumors.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Endoscopic ultrasound is an established examination method for tumors of the gastrointestinal
      tract and the pancreas. Since imaging by itself is limited in differential diagnosis of
      tumors, EUS guided fine needle aspiration is seen as a valid complementary method. Since
      fine-needle aspiration (FNA) is mainly based on cytological diagnostics, this method is
      limited also because of lacking supplementary immune- histochemical diagnostics. Here, the
      obtainment of little histologically evaluable tissue samples (punched barrels) would be of
      benefit.

      A new punch needle device called Pro-core needle (Cook)(22 / 19 gauges) offers the
      possibility of increasing numbers of valid extractions of histologically evaluable tissues
      due to a better targeted precision and maneuverability in comparison to other devices of that
      kind (tru-cut needles, e.g.). A little notch at the pinpoint allows the obtainment of little
      tissue samples, that will be kept within the device by aspiration.

      This study compares the obtainment of tissue by Proc-core needle and conventional aspiration
      punction systems.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2011</start_date>
  <completion_date type="Actual">October 2014</completion_date>
  <primary_completion_date type="Actual">October 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Diagnostic Accuracy</measure>
    <time_frame>up to 1 year</time_frame>
    <description>Diagnostic accuracy of Pro-core needle (22 G) will be compared to conventional fine needle aspiration (22 G). Therefore EUS-FNA with both needles is undertaken in a random order in each lesion. For Pro-core needle, a histological / cytological diagnosis and quality assessment will be made by pathologists.For Echotip aspiration needle, reference cytology evaluation is done by cytology experts.
The histopathological diagnosis after surgery or the clinical follow up of at least one year after EUS FNA is current standard.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>EUS Pro Core FNA: Histology Samples</measure>
    <time_frame>day 0 and day 14</time_frame>
    <description>Histology (not cytology) samples for Pro-core Needle: Number of adequately evaluable histology samples</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complication Rates</measure>
    <time_frame>day 0 and day 14</time_frame>
    <description>Complication rates of EUS FNA</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">56</enrollment>
  <condition>Pancreatic Neoplasm</condition>
  <arm_group>
    <arm_group_label>EUS guided FNA and fine needle punction</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>punction of endosonographically identified space-occupying process with aspirating fine needle and pro core fine needle in a randomized order</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>EUS guided FNA and fine needle punction</intervention_name>
    <description>punction of a suspect area by a EUS guided fine needle as well as pro core fine needle to evacuate histology and smear biologics</description>
    <arm_group_label>EUS guided FNA and fine needle punction</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  clinical indication for endoscopic ultrasound diagnostics with fine needle biopsies

          -  age greater than 18 years

        Exclusion Criteria:

          -  difficult or impossible approach to desired structures due to anatomy (postoperative
             anatomy, e.g.)

          -  cystic lesion, e.g. cystic pancreas tumors

          -  coagulopathy

          -  severe general condition of the patient

          -  other contraindications for endoscopical ultrasound aided fine needle punction
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas Rösch, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Eppendorf, Hamburg</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Universitätsklinikum Hamburg-Eppendorf</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Parikh P, Shiloach M, Cohen ME, Bilimoria KY, Ko CY, Hall BL, Pitt HA. Pancreatectomy risk calculator: an ACS-NSQIP resource. HPB (Oxford). 2010 Sep;12(7):488-97. doi: 10.1111/j.1477-2574.2010.00216.x.</citation>
    <PMID>20815858</PMID>
  </reference>
  <reference>
    <citation>van der Gaag NA, Rauws EA, van Eijck CH, Bruno MJ, van der Harst E, Kubben FJ, Gerritsen JJ, Greve JW, Gerhards MF, de Hingh IH, Klinkenbijl JH, Nio CY, de Castro SM, Busch OR, van Gulik TM, Bossuyt PM, Gouma DJ. Preoperative biliary drainage for cancer of the head of the pancreas. N Engl J Med. 2010 Jan 14;362(2):129-37. doi: 10.1056/NEJMoa0903230.</citation>
    <PMID>20071702</PMID>
  </reference>
  <reference>
    <citation>Möller K, Papanikolaou IS, Toermer T, Delicha EM, Sarbia M, Schenck U, Koch M, Al-Abadi H, Meining A, Schmidt H, Schulz HJ, Wiedenmann B, Rösch T. EUS-guided FNA of solid pancreatic masses: high yield of 2 passes with combined histologic-cytologic analysis. Gastrointest Endosc. 2009 Jul;70(1):60-9. doi: 10.1016/j.gie.2008.10.008. Epub 2009 Apr 25.</citation>
    <PMID>19394012</PMID>
  </reference>
  <reference>
    <citation>Takahashi K, Yamao K, Okubo K, Sawaki A, Mizuno N, Ashida R, Koshikawa T, Ueyama Y, Kasugai K, Hase S, Kakumu S. Differential diagnosis of pancreatic cancer and focal pancreatitis by using EUS-guided FNA. Gastrointest Endosc. 2005 Jan;61(1):76-9.</citation>
    <PMID>15672060</PMID>
  </reference>
  <reference>
    <citation>Iglesias-Garcia J, Dominguez-Munoz E, Lozano-Leon A, Abdulkader I, Larino-Noia J, Antunez J, Forteza J. Impact of endoscopic ultrasound-guided fine needle biopsy for diagnosis of pancreatic masses. World J Gastroenterol. 2007 Jan 14;13(2):289-93.</citation>
    <PMID>17226911</PMID>
  </reference>
  <reference>
    <citation>Südhoff T, Hollerbach S, Wilhelms I, Willert J, Reiser M, Topalidis T, Schmiegel W, Graeven U. [Clinical utility of EUS-FNA in upper gastrointestinal and mediastinal disease]. Dtsch Med Wochenschr. 2004 Oct 15;129(42):2227-32. German.</citation>
    <PMID>15483756</PMID>
  </reference>
  <reference>
    <citation>Aithal GP, Anagnostopoulos GK, Tam W, Dean J, Zaitoun A, Kocjan G, Ragunath K, Pereira SP. EUS-guided tissue sampling: comparison of &quot;dual sampling&quot; (Trucut biopsy plus FNA) with &quot;sequential sampling&quot; (Trucut biopsy and then FNA as required). Endoscopy. 2007 Aug;39(8):725-30. Epub 2007 Jul 10.</citation>
    <PMID>17620230</PMID>
  </reference>
  <reference>
    <citation>Wittmann J, Kocjan G, Sgouros SN, Deheragoda M, Pereira SP. Endoscopic ultrasound-guided tissue sampling by combined fine needle aspiration and trucut needle biopsy: a prospective study. Cytopathology. 2006 Feb;17(1):27-33.</citation>
    <PMID>16417562</PMID>
  </reference>
  <reference>
    <citation>Shah SM, Ribeiro A, Levi J, Jorda M, Rocha-Lima C, Sleeman D, Hamilton-Nelson K, Ganjei-Azar P, Barkin J. EUS-guided fine needle aspiration with and without trucut biopsy of pancreatic masses. JOP. 2008 Jul 10;9(4):422-30.</citation>
    <PMID>18648133</PMID>
  </reference>
  <reference>
    <citation>Storch I, Shah M, Thurer R, Donna E, Ribeiro A. Endoscopic ultrasound-guided fine-needle aspiration and Trucut biopsy in thoracic lesions: when tissue is the issue. Surg Endosc. 2008 Jan;22(1):86-90. Epub 2007 May 4.</citation>
    <PMID>17479313</PMID>
  </reference>
  <reference>
    <citation>Storch I, Jorda M, Thurer R, Raez L, Rocha-Lima C, Vernon S, Ribeiro A. Advantage of EUS Trucut biopsy combined with fine-needle aspiration without immediate on-site cytopathologic examination. Gastrointest Endosc. 2006 Oct;64(4):505-11. Epub 2006 Jun 6.</citation>
    <PMID>16996340</PMID>
  </reference>
  <reference>
    <citation>Săftoiu A, Vilmann P, Guldhammer Skov B, Georgescu CV. Endoscopic ultrasound (EUS)-guided Trucut biopsy adds significant information to EUS-guided fine-needle aspiration in selected patients: a prospective study. Scand J Gastroenterol. 2007 Jan;42(1):117-25.</citation>
    <PMID>17190771</PMID>
  </reference>
  <reference>
    <citation>Sakamoto H, Kitano M, Komaki T, Noda K, Chikugo T, Dote K, Takeyama Y, Das K, Yamao K, Kudo M. Prospective comparative study of the EUS guided 25-gauge FNA needle with the 19-gauge Trucut needle and 22-gauge FNA needle in patients with solid pancreatic masses. J Gastroenterol Hepatol. 2009 Mar;24(3):384-90. doi: 10.1111/j.1440-1746.2008.05636.x. Epub 2008 Nov 20.</citation>
    <PMID>19032453</PMID>
  </reference>
  <reference>
    <citation>Siddiqui UD, Rossi F, Rosenthal LS, Padda MS, Murali-Dharan V, Aslanian HR. EUS-guided FNA of solid pancreatic masses: a prospective, randomized trial comparing 22-gauge and 25-gauge needles. Gastrointest Endosc. 2009 Dec;70(6):1093-7. doi: 10.1016/j.gie.2009.05.037. Epub 2009 Jul 28.</citation>
    <PMID>19640524</PMID>
  </reference>
  <reference>
    <citation>Jenssen C, Faiss S, Nürnberg D. [Complications of endoscopic ultrasound and endoscopic ultrasound-guided interventions - results of a survey among German centers]. Z Gastroenterol. 2008 Oct;46(10):1177-84. doi: 10.1055/s-2008-1027334. Epub 2008 Oct 20. German.</citation>
    <PMID>18937186</PMID>
  </reference>
  <reference>
    <citation>Bournet B, Migueres I, Delacroix M, Vigouroux D, Bornet JL, Escourrou J, Buscail L. Early morbidity of endoscopic ultrasound: 13 years' experience at a referral center. Endoscopy. 2006 Apr;38(4):349-54.</citation>
    <PMID>16680633</PMID>
  </reference>
  <reference>
    <citation>Mortensen MB, Fristrup C, Holm FS, Pless T, Durup J, Ainsworth AP, Nielsen HO, Hovendal C. Prospective evaluation of patient tolerability, satisfaction with patient information, and complications in endoscopic ultrasonography. Endoscopy. 2005 Feb;37(2):146-53.</citation>
    <PMID>15692930</PMID>
  </reference>
  <reference>
    <citation>Al-Haddad M, Wallace MB, Woodward TA, Gross SA, Hodgens CM, Toton RD, Raimondo M. The safety of fine-needle aspiration guided by endoscopic ultrasound: a prospective study. Endoscopy. 2008 Mar;40(3):204-8. Epub 2007 Dec 4.</citation>
    <PMID>18058615</PMID>
  </reference>
  <reference>
    <citation>Williams DB, Sahai AV, Aabakken L, Penman ID, van Velse A, Webb J, Wilson M, Hoffman BJ, Hawes RH. Endoscopic ultrasound guided fine needle aspiration biopsy: a large single centre experience. Gut. 1999 May;44(5):720-6.</citation>
    <PMID>10205212</PMID>
  </reference>
  <reference>
    <citation>O'Toole D, Palazzo L, Arotçarena R, Dancour A, Aubert A, Hammel P, Amaris J, Ruszniewski P. Assessment of complications of EUS-guided fine-needle aspiration. Gastrointest Endosc. 2001 Apr;53(4):470-4.</citation>
    <PMID>11275888</PMID>
  </reference>
  <reference>
    <citation>Wiersema MJ, Vilmann P, Giovannini M, Chang KJ, Wiersema LM. Endosonography-guided fine-needle aspiration biopsy: diagnostic accuracy and complication assessment. Gastroenterology. 1997 Apr;112(4):1087-95.</citation>
    <PMID>9097990</PMID>
  </reference>
  <reference>
    <citation>Buscarini E, De Angelis C, Arcidiacono PG, Rocca R, Lupinacci G, Manta R, Carucci P, Repici A, Carrara S, Vallisa D, Buscarini L, Cosentino F, Pera A, Rizzetto M, Testoni PA, Zambelli A. Multicentre retrospective study on endoscopic ultrasound complications. Dig Liver Dis. 2006 Oct;38(10):762-7. Epub 2006 Jul 13.</citation>
    <PMID>16843076</PMID>
  </reference>
  <verification_date>August 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 8, 2013</study_first_submitted>
  <study_first_submitted_qc>July 2, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 3, 2014</study_first_posted>
  <results_first_submitted>May 21, 2015</results_first_submitted>
  <results_first_submitted_qc>August 15, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">September 16, 2015</results_first_posted>
  <last_update_submitted>August 15, 2015</last_update_submitted>
  <last_update_submitted_qc>August 15, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 16, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universitätsklinikum Hamburg-Eppendorf</investigator_affiliation>
    <investigator_full_name>Prof. Dr. Thomas Rösch</investigator_full_name>
    <investigator_title>Medical Director, Interdisciplinary Endoscopy Department and Clinic</investigator_title>
  </responsible_party>
  <keyword>fine needle aspiration</keyword>
  <keyword>core biopsy</keyword>
  <keyword>endoscopic ultrasound</keyword>
  <keyword>space occupying process mediastinal, perigastral, perihilar</keyword>
  <keyword>suspect lymph nodes mediastinal, perigastral or perihilar</keyword>
  <keyword>diagnostic accuracy of EUS guided core biopsy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatic Neoplasms</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>EUS Guided FNA and Fine Needle Punction</title>
          <description>punction of endosonographically identified space-occupying process with aspirating fine needle and pro core fine needle in a randomized order
EUS guided FNA and fine needle punction: punction of a suspect area by a EUS guided fine needle as well as pro core fine needle to evacuate histology and smear biologics</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="56"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="56"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>EUS Guided FNA and Fine Needle Punction</title>
          <description>punction of endosonographically identified space-occupying process with aspirating fine needle and pro core fine needle in a randomized order
EUS guided FNA and fine needle punction: punction of a suspect area by a EUS guided fine needle as well as pro core fine needle to evacuate histology and smear biologics</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="56"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="67.5" lower_limit="34" upper_limit="87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Germany</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Diagnostic Accuracy</title>
        <description>Diagnostic accuracy of Pro-core needle (22 G) will be compared to conventional fine needle aspiration (22 G). Therefore EUS-FNA with both needles is undertaken in a random order in each lesion. For Pro-core needle, a histological / cytological diagnosis and quality assessment will be made by pathologists.For Echotip aspiration needle, reference cytology evaluation is done by cytology experts.
The histopathological diagnosis after surgery or the clinical follow up of at least one year after EUS FNA is current standard.</description>
        <time_frame>up to 1 year</time_frame>
        <group_list>
          <group group_id="O1">
            <title>EUS Guided Pro Core FNA</title>
            <description>EUS guided punction of a lesion by pro core fine needle to evacuate histology and smear biologics</description>
          </group>
        </group_list>
        <measure>
          <title>Diagnostic Accuracy</title>
          <description>Diagnostic accuracy of Pro-core needle (22 G) will be compared to conventional fine needle aspiration (22 G). Therefore EUS-FNA with both needles is undertaken in a random order in each lesion. For Pro-core needle, a histological / cytological diagnosis and quality assessment will be made by pathologists.For Echotip aspiration needle, reference cytology evaluation is done by cytology experts.
The histopathological diagnosis after surgery or the clinical follow up of at least one year after EUS FNA is current standard.</description>
          <units>Diagnostic accuracy (%)</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="56"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>EUS Pro Core FNA: Histology Samples</title>
        <description>Histology (not cytology) samples for Pro-core Needle: Number of adequately evaluable histology samples</description>
        <time_frame>day 0 and day 14</time_frame>
        <population>Histology (not cytology) samples for Pro-core Needle</population>
        <group_list>
          <group group_id="O1">
            <title>EUS Guided Pro Core FNA</title>
            <description>EUS guided Pro core FNA: Histology samples (not cytology)</description>
          </group>
        </group_list>
        <measure>
          <title>EUS Pro Core FNA: Histology Samples</title>
          <description>Histology (not cytology) samples for Pro-core Needle: Number of adequately evaluable histology samples</description>
          <population>Histology (not cytology) samples for Pro-core Needle</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="56"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Complication Rates</title>
        <description>Complication rates of EUS FNA</description>
        <time_frame>day 0 and day 14</time_frame>
        <group_list>
          <group group_id="O1">
            <title>EUS Guided FNA</title>
            <description>EUS FNA of lesions with aspirating fine needle and pro core fine needle in a randomized order</description>
          </group>
        </group_list>
        <measure>
          <title>Complication Rates</title>
          <description>Complication rates of EUS FNA</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="56"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 fortnight</time_frame>
      <group_list>
        <group group_id="E1">
          <title>EUS Guided FNA</title>
          <description>EUS FNA of lesions with aspirating fine needle and pro core fine needle in a randomized order</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="56"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="56"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Professor Dr. Thomas Rösch</name_or_title>
      <organization>Interdisciplinary Endoscopy Department and Clinic University Hospital Hamburg-Eppendorf</organization>
      <phone>+4940 7410 ext 50098</phone>
      <email>t.roesch@uke.de</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

